Valuing the broader benefits of dengue vaccination, with a preliminary application to Brazil

Seminars in Immunology

Volumn 25, Issue 2, 2013, Pages 104-113

  Bärnighausen, Till ^a,b   Bloom, David E ^a   Cafiero, Elizabeth T ^a   O'Brien, Jennifer C ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Dengue; Economic evaluation; Immunization; Vaccination; Vaccine

Indexed keywords

DENGUE VACCINE;

BRAZIL; COST EFFECTIVENESS ANALYSIS; DENGUE; DISEASE SURVEILLANCE; ECONOMIC EVALUATION; HUMAN; INCIDENCE; OUTCOME ASSESSMENT; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH; REVIEW; VACCINATION; VECTOR CONTROL;

DENGUE; ECONOMIC EVALUATION; IMMUNIZATION; VACCINATION; VACCINE;

ANIMALS; BRAZIL; COST-BENEFIT ANALYSIS; DENGUE; DENGUE VACCINES; HUMANS; QUALITY IMPROVEMENT;

EID: 84882263032     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2013.04.010     Document Type: Review

References (97)

1. World Health Organization Global strategy for dengue prevention and control 2012-2020 2012, World Health Organization, Geneva.
2. World Health Organization Dengue and dengue haemorrhagic fever: fact sheet #117 2009, World Health Organization, Geneva, Available from: http://www.who.int/mediacentre/factsheets/fs117/en/.
3. World Health Organization Dengue guidelines for diagnosis, treatment, prevention, and control. Geneva 2009, Available from: http://www.who.int/rpc/guidelines/9789241547871/en/.
4. Brady O.J., Gething P.W., Bhatt S., Messina J.P., Brownstein J.S., Hoen A.G., et al. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLOS Neglected Tropical Diseases 2012, 6(8):e1760.
5. Whitehorn J., Farrar J. Dengue. British Medical Bulletin 2010, 95(September (1)):161-173.
6. United Nations Population Division World population Prospects: the 2010 revision [Internet]. United Nations 2011.
7. Cattand P., Desjeux P., Guzman M.G., Jannin J., Kroeger A., Medici A., et al. Tropical diseases lacking adequate control measures: dengue, leishmaniasis, and African trypamsomiasis. Disease Control Priorities 2006, 451-466. Oxford University Press, New York. 2nd ed. D.T. Jamison, J.G. Breman, A.R. Measham, G. Alleyne, M. Claeson, D.B. Evans, P. Jha, A. Mills, P. Musgrove (Eds.).
8. Ranjit S., Kissoon N. Dengue hemorrhagic fever and shock syndromes. Pediatric Critical Care Medicine 2011, 12(January (1)):90-100.
9. Lozano R., Naghavi M., Foreman K., Lim S., Shibuya K., Aboyans V., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013, 380(December (9859)):2095-2128.
10. Shepard D.S., Coudeville L., Halasa Y.A., Zambrano B., Dayan G.H. Economic impact of dengue illness in the Americas. American Journal of Tropical Medicine and Hygiene 2011, 84(February (2)):200-207.
11. Perapaddan B.S. Quacks thriving on dengue panic: doctors 2006, The Hindu, New Delhi, [cited 31.01.13].
12. Safdar S. Quacks who cried dengue's cure... 2011, Pakistan Today, Lahore, [cited 31.01.13].
13. Lang J. Development of Sanofi Pasteur tetravalent dengue vaccine. Revista do Instituto de Medicina Tropical de Sao Paulo 2012, 54(Suppl 18):S15-S20.
14. Lam S.K., Burke D., Capeding M.R., Chong C.K., Coudeville L., Farrar J., et al. Preparing for introduction of a dengue vaccine: recommendations from the 1st Dengue v2V Asia-Pacific Meeting. Vaccine 2011, 28(November (2951)):9417-9422.
15. Dengue Vaccine Initiative Report of the Americas Dengue Prevention Board meeting: points for consideration for first introductions of dengue vaccines 2012, Dengue Vaccine Initiative.
16. Coller B.-A.G., Clements D.E. Dengue vaccines: progress and challenges. Current Opinion in Immunology 2011, 23:391-398.
17. Schmitz J., Roehrig J., Barrett A., Hombach J. Next generation dengue vaccines: a review of candidates in preclinical development. Vaccine 2011, 29:7276-7284.
18. Sabchareon A., Wallace D., Sirivichayakul C., Limkittikul K., Chanthavanich P., Suvannadabba S., et al. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet 2012, 380(November (9853)):1559-1567.
19. Jit M., Brisson M. Modelling the epidemiology of infectious diseases for decision analysis: a primer. Pharmacoeconomics 2011, 29(May (5)):371-386.
20. Bärnighausen T., Bloom D.E., Cafiero E.T., O'Brien J.C. Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus. Clinical Microbiology and Infection 2012, (October (18 Suppl. 5)):70-76.
21. Bärnighausen T., Bloom D.E., Canning D., Friedman A., Levine O.S., O'Brien J., et al. Rethinking the benefits and costs of childhood vaccination: the example of the Haemophilus influenzae type b vaccine. Vaccine 2011, 29(March (13)):2371-2380.
22. Centers for Disease Control and Prevention CDC vaccine price list [Internet] 2012, [cited 10.01.12].
23. World Health Organization WHO vaccine-preventable diseases: monitoring system, 2012 global 2012, World Health Organization, Geneva.
24. Pan American Health Organization Revolving fund vaccine prices 2013, PAHO/WHO, Washington, DC, Available from: http://new.paho.org/hq/index.php?option=com_content&view=article&id=1864&Itemid=2234&lang=en [cited 01.03.2013].
25. Bloom D.E., Canning D. The health and wealth of nations. Science 2000, 287(February (5456)):1207-1209.
26. Anekwe T., Newell M., Bärnighausen T. The impact of measles vaccination on educational attainment in rural KwaZulu-Natal. Presentation at GAVI Alliance meeting in Annecy 2013.
27. Bloom D., Fink G. The economic case for devoting public resources to health. Manson's tropical diseases 2013, Elsevier, [forthcoming]. 23rd ed. J. Farrar, N. White, D. Lalloo, P. Hotez, T. Junghanss, G. Kang (Eds.).
28. Bloom D.E. 7 Billion and counting. Science 2011, 333(6042):562-569.
29. Bloom D.E., Canning D., Mansfield R., Moore M. Demographic change, social security systems, and savings. Journal of Monetary Economics 2007, 54:92-114.
30. Alsan M., Bloom D.E., Canning D. The effect of population health on foreign direct investment inflows to low- and middle-income countries. World Development 2006, 34(4):613-630.
31. Bärnighausen T., Bloom D.E., Canning D., O'Brien J. Accounting for the full benefits of childhood vaccination in South Africa. South African Medical Journal 2008, 98(November (11)):842. 4-6.
32. Bloom D., Canning D., Weston M. The value of vaccination. World Economics 2005, 6(3):15-39.
33. Bloom D.E., Canning D., Shenoy E.S. The effect of vaccination on children's physical and cognitive development in the Philippines. Applied Economics 2012, 44(21):2777-2783.
34. World Bank Learning for all: investing in people's knowledge and skills to promote development 2011, World Bank, Washington, DC.
35. Bärnighausen T., Bloom D.E., Cafiero E.T., O'Brien J.C. New thinking on the value of vaccination, globally and in India. IAP Textbook of Vaccines 2013, Jaypee Brothers Medical Publishers, New Delhi, [forthcoming].
36. World Health Organization Haemophilus influenzae type B (Hib) 2005, Available from: http://www.who.int/mediacentre/factsheets/fs294/en/ [cited 15.10.2010].
37. Canning D., Razzaque A., Driessen J., Walker D.G., Streatfield P.K., Yunus M. The effect of maternal tetanus immunization on children's schooling attainment in Matlab, Bangladesh: follow-up of a randomized trial. Social Science & Medicine 2011, 72(May (9)):1429-1436.
38. Dewey K.G., Begum K. Long-term consequences of stunting in early life. Maternal & Child Nutrition 2011, (October (7 Suppl. 3)):5-18.
39. Bloom D., Canning D., Fink G., Finlay J. Fertility, female labor force participation, and the demographic dividend. Journal of Economic Growth 2009, 14:79-101.
40. Bloom D.E. India's baby boomers: dividend or disaster?. Current History 2011, 110:143-149.
41. Bloom D.E. Population dynamics in India and implications for economic growth. The Oxford Handbook of the Indian Economy 2012, Oxford University Press, Oxford. C. Ghate (Ed.).
42. John T.J., Samuel R. Herd immunity and herd effect: new insights and definitions. European Journal of Epidemiology 2000, 16(7):601-606.
43. Roberts R.R., Mensah E.K., Weinstein R.A. A guide to interpreting economic studies in infectious diseases. Clinical Microbiology and Infection 2010, 16(December (12)):1713-1720.
44. Asiedu E., Jin Y., Kalonda-KanyamaI I. The impact of HIV/AIDS on foreign direct investment: Evidence from Sub-Saharan Africa, in Working Papers Series in Theoretical and Applied Economics, No. 201207 2012, University of Kansas, Department of Economics.
45. World Health Organization Cervical cancer, human papillomavirus (HPV), and HPV vaccines: key points for policy-makers and health professionals 2007, World Health Organization, Geneva.
46. Rice D.P. Estimating the cost of illness. Health economics series no. 6. 1966, US Government Printing Office, Washington, DC.
47. Viscusi W.K., Aldy J.E. The value of a statistical life: a critical review of market estimates throughout the world 2003, National Bureau of Economic Research Working Paper Series, No. 9487.
48. Bloom D.E., Canning D., Shenoy E.S. The effect of vaccination on cognitive development in the Philippines September 2007, Mimeo.
49. Driessen J., Razzaque A., Walker D., Canning D. The effect of childhood measles vaccination on school enrollment in Matlab, Bangladesh. PGDA Working Paper No 81 2011, Program on the Global Demography of Aging, Cambridge.
50. Psacharopoulos G., Patrinos H.A. Returns to investment in education: a further update. Education Economics 2004, 12(2):113-134.
51. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer Journal International du Cancer 2010, 127(12):2893-2917.
52. International Labor Organization LABORSTA statistics database 2011, International Labor Organization, Geneva.
53. Deogaonkar R., Hutubessy R., van der Putten I., Evers S., Jit M. Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries. BMC Public Health 2012, 12:878.
54. Central Intelligence Agency The world factbook 2013 2013, Central Intelligence Agency, Washington, DC, Available from: https://www.cia.gov/library/publications/the-world-factbook/geos/br.html [cited 19.07.13].
55. Teixeira M.G., Costa M.d.C.N., Barreto F., Barreto M.L. Dengue: twenty-five years since reemergence in Brazil. Cadernos de Saude Publica 2009, 25(Suppl. 1):S7-S18.
56. Ministerio de Saúde Balanço dengue Janeiro a Abril de 2012 2012.
57. Globo News Dengue tipo 4 preocupa porque afeta quem já teve outros tipos, diz infectologista. G1Globo [Internet] 2013, January, Available from: http://g1.globo.com/globo-news/noticia/2013/01/dengue-tipo-4-preocupa-porque-afeta-quem-ja-teve-outros-tipos-diz-infectologista.html[cited 19.01.13].
58. Rodriguez-Barraquer I., Cordeiro M.T., Braga C., deSouza W.V., Marques E.T., Cummings D.A.T. From re-emergence to hyperendemicity: the natural history of the dengue epidemic in Brazil. PLoS Neglected Tropical Diseases 2011, 5(1):e935.
59. Teixeira M.G. Few characteristics of dengue's fever epidemiology in Brazil. Revista do Instituto de Medicina Tropical de São Paulo 2012, 54(Suppl. 18):S1-S4.
60. Siqueira J.B., Martelli C.M.T., Coelho G.E., Simplício ACdR, Hatch D.L. Dengue and dengue hemorrhagic fever, Brazil, 1981-2002. Emerging Infectious Diseases 2005, 11(1):48-53.
61. Verguet S., Laxminarayan R., Jamison D. Universal public finance of tuberculosis treatment in india: an extended cost-effectiveness analysis 2012, Disease control priorities network, Seattle, Washington. 3rd ed.
62. Suaya J.A., Shepard D.S., Siqueira J.B., Martelli C.T., Lum L.C.S., Tan L.H., et al. Cost of dengue cases in eight countries in the Americas and Asia: a prospective study. American Journal of Tropical Medicine and Hygiene 2009, 80(5):846-855.
63. Simmons C.P., Farrar J.J., Nguyen v.V., Wills B. Dengue. New England Journal of Medicine 2012, 366:1423-1432.
64. Finsterer J., Kongchan K. Severe, persisting, steroid-responsive dengue myositis. Journal of Clinical Virology 2006, 35:426-428.
65. Utah Public Health - Bureau of Epidemiology Disease investigation plans, dengue fever (dengue hemorrhagic fever) (dengue shock syndrome) 2011, Utah Department of Health, Utah.
66. Govt. of India, National Vector Borne Disease Control Programme, Directorate General of Health Services, Ministry of Health & Family Welfare. Do's and don't's for managing dengue fever/dengue haemorrhagic fever cases. Delhi: National Vector Borne Disease Control Program; 2006.
67. Ministère de la santé de la jeunesse et des sports, Direction générale de la Santé Generalites sur la dengue 2007, Direction générale de la Santé, Paris.
68. Garcia G., Gonzalez N., Perez A.B., Sierra B., Aguirre E., Rizo D., et al. Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disorders. International Journal of Infectious Diseases 2011, 15:e38-e43.
69. Low J.G.H., Ooi E.-E., Tolfvenstam T., Leo Y.-S., Hibberd M.L., Ng L.-C., et al. Early dengue infection and outcome study (EDEN) - study design and preliminary findings. Annals of the Academy of Medicine, Singapore 2006, 35:783-789.
70. Teixeira L.d.S., Lopes J.S.M., Martins A.G.d.C., Campos F.A.B., Miranzi S.d.S.C., Nascentes G.A.N. Persistence of dengue symptoms in patients in Uberaba, Minas Gerais State, Brazil. Cadernos de Saude Publica 2010, 26(3):625-630.
71. Seet R.C.S., Quek A.M.L., Lima E.C.H. Post-infectious fatigue syndrome in dengue infection. Journal of Clinical Virology 2007, 38:1-6.
72. Tristão-Sá R., Kubelka C.F., Zandonade E., Zagne S.M.O., Rocha N.d.S.M., Zagne L.O., et al. Clinical and hepatic evaluation in adult dengue patients: a prospective two-month cohort study. Revista da Sociedade Brasileira de Medicina Tropical 2012, 45(6):675-681.
73. Hemp P. Presenteeism: at work - but out of it. Harvard Business Review 2004, 82(10):49-58.
74. Keech M., Beardsworth P. The impact of influenza on working days lost: a review of the literature. Pharmacoeconomics 2008, 26(11):911-924.
75. Keech M., Scott A.J., Ryan P.J.J. The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population. Occupational Medicine 1998, 48(2):85-90.
76. Lee B.Y., Brown S.T., Cooley P.C., Zimmerman R.K., Wheaton W.D., Zimmer S.M., et al. A computer simulation of employee vaccination to mitigate an influenza epidemic. American Journal of Preventive Medicine 2010, 38(3):247-257.
77. Rothberg M.B., Haessler S.D., Brown R.B. Complications of viral influenza. American Journal of Medicine 2008, 121:258-264.
78. Brown S.T., Tai J.H., Bailey R.R., Cooley P.C., Wheaton W.D., Potter M.A., et al. Would school closure for the 2009 H1N1 influenza epidemic have been worth the cost?: a computational simulation of Pennsylvania. BMC Public Health 2011, 11:353.
79. Molinari N-AM, Ortega-Sanchez I.R., Messonnier M.L., Thompson W.W., Wortley P.M., Weintraub E., et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007, 25:5086-5096.
80. Mao L., Yang Y., Qiu Y., Yang Y. Annual economic impacts of seasonal influenza on US counties: spatial heterogeneity and patterns. International Journal of Health Geographics 2012, 11:16.
81. Commission on Macroeconomics and Health Macroeconomics and health: investing in health for economic development: report of the Commission on Macroeconomics and Health 2001, World Health Organization, Geneva.
82. Tam J. SARS slashes FDI inflows by 62 per cent. The Standard: Greater China's Business Newspaper 2003, 1 October.
83. Business Daily Update Expectation of 2003 actual FDI lowered. Financial Times Information, Global News Wire: Asia Africa Intelligence Wire [Internet] 2003.
84. Ernst & Young Capturing the momentum: Ernst & Young's 2012 Attractiveness Survey, Brazil 2012, EYGM Limited, UK.
85. Ministério do Turismo Anuário Estatístico de Turismo - 2012 2012, Ministério do Turismo, Brasilia DF, Brasil.
86. Equipe No Pátio Turismo Brasileiro com novo recorde em 2011. nopatiocombr [Internet] 2012, Available from: http://www.nopatio.com.br/o-que-acontece/turismo-brasileiro-com-novo-recorde-em-2011/.
87. World Travel & Tourism Council Travel and tourism: economic impact. Brazil 2012. London WTTC 2012.
88. Sistema de Informação de Agravos de Notificação - Sinan Net, Dengue [Internet]. Ministério da Saúde/SVS 2013 [cited August 20]. Available from:. http://dtr2004.saude.gov.br/sinanweb/tabnet/dh?sinannet/dengue/bases/denguebrnet.def.
89. Galanternick M., Barrionuevo A. Dengue outbreak sweeps through Rio. The New York Times [Internet] 2008, Available from: http://www.nytimes.com/2008/04/15/world/americas/15dengue.html.
90. BBC Dengue é repelente para turistas', diz jornal argentino. G1Globocom [Internet]. 2008, March 12 2012, Available from: http://g1.globo.com/Noticias/Brasil/0,MUL396654-5598,00-DENGUE+E+REPELENTE+PARA+TURISTAS+DIZ+JORNAL+ARGENTINO.html.
91. Folha de São Paulo Dengue faz turismo cair até 30% no Rio, diz associação. Folha Online [Internet] 2008, Available from: http://www1.folha.uol.com.br/folha/cotidiano/ult95u394379.shtml.
92. Clarin.com La epidemia de dengue en Brasil está fuera de control y ya afecta al turismo 2008, Available from: http://edant.clarin.com/diario/2008/04/10/um/m-01647946.htm.
93. Mavalankar D.V., Puwar T.I., Murtola T.M., Vasan S.S. Quantifying the impact of chikungunya and dengue on tourism revenues. W.P. No. 2009-02-03 2009, Indian Institute of Management, Ahmedabad, India.
94. Paim J., Travassos C., Almeida C., Bahia L., Macinko J. The Brazilian health system: history, advances, and challenges. Lancet 2011, 377(9779):1778-1797.
95. World Health Organization Flawed but fair: Brazil's health system reaches out to the poor. Bulletin of the World Health Organization 2008, 86(4):248-249.
96. The Economist Health care in Brazil: an injection of reality. The Economist 2011 July 30, print edition.
97. Portal da Saude S.U.S. Ministério da Saúde repassa R$ 173 milhões para combate à dengue 2013 January 30, Available from: http://portalsaude.saude.gov.br/portalsaude/maisNoticias/376/2.